Atossa Therapeutics, Inc.
ATOS
$0.6231
$0.01812.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.07% | -16.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.00% | -10.13% | |||
| Operating Income | -12.00% | 10.13% | |||
| Income Before Tax | 12.21% | -19.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.21% | -19.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.21% | -19.52% | |||
| EBIT | -12.00% | 10.13% | |||
| EBITDA | -12.00% | 10.14% | |||
| EPS Basic | 12.87% | -19.54% | |||
| Normalized Basic EPS | -14.23% | 8.97% | |||
| EPS Diluted | 12.87% | -19.54% | |||
| Normalized Diluted EPS | -14.23% | 8.97% | |||
| Average Basic Shares Outstanding | 0.67% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.67% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||